Anti-leukemia activity of PVP-coated silver nanoparticles via generation of reactive oxygen species and release of silver ions

Biomaterials

Volumn 34, Issue 32, 2013, Pages 7884-7894

  Guo, Dawei ^a,b   Zhu, Lingying ^a,b   Huang, Zhihai ^a,b   Zhou, Haixia ^c   Ge, Yue ^c   Ma, Wenjuan ^c   Wu, Jie ^c   Zhang, Xiuyan ^c   Zhou, Xuefeng ^a,b   Zhang, Yu ^a   Zhao, Yun ^c   Gu, Ning ^a,b  

^a Southeast University   (China)

^b SOUTHEAST UNIVERSITY   (China)

^c SOOCHOW UNIVERSITY   (China)

Author keywords

Acute myeloid leukemia; Cytotoxicity; Reactive oxygen species; Silver ions; Silver nanoparticles

Indexed keywords

ACUTE MYELOID LEUKEMIA; CYTOTOXIC EFFECTS; MITOCHONDRIAL MEMBRANE POTENTIAL; PRODUCTION OF; REACTIVE OXYGEN SPECIES; SILVER IONS; SILVER NANOPARTICLES; SILVER NANOPARTICLES (AGNPS);

AMINO ACIDS; CELL DEATH; CYTOTOXICITY; DISEASES; METAL IONS; NANOPARTICLES; OXYGEN;

SILVER;

ACETYLCYSTEINE; ASCORBIC ACID; POVIDONE; REACTIVE OXYGEN METABOLITE; SILVER NANOPARTICLE;

ACUTE GRANULOCYTIC LEUKEMIA; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL VIABILITY; CYTOTOXICITY; DNA DAMAGE; DRUG COATING; HUMAN; HUMAN CELL; LEUKEMIA CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL;

EID: 84881026592     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.07.015     Document Type: Article

References (63)

1. Bonnet D., Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997, 3(7):730-737.
2. Cheson B.D., Cassileth P.A., Head D.R., Schiffer C.A., Bennett J.M., Bloomfield C.D., et al. Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. JClin Oncol 1990, 8(5):813-819.
3. Robak T., Wierzbowska A. Current and emerging therapies for acute myeloid leukemia. Clin Ther 2009, 31(2):2349-2370.
4. Johnston H.J., Hutchison G., Christensen F.M., Peters S., Hankin S., Stone V. Areview of the invivo and invitro toxicity of silver and gold particulates: particle attributes and biological mechanisms responsible for the observed toxicity. Crit Rev Toxicol 2010, 40(4):328-346.
5. Alarcon E.I., Udekwu K., Skog M., Pacioni N.L., Stamplecoskie K.G., Gonzalez-Bejar M., et al. The biocompatibility and antibacterial properties of collagen-stabilized, photochemically prepared silver nanoparticles. Biomaterials 2012, 33(19):4947-4956.
6. Huang Z., Jiang X., Guo D., Gu N. Controllable synthesis and biomedical applications of silver nanomaterials. JNanosci Nanotechnol 2011, 11(11):9395-9408.
7. Panacek A., Kolar M., Vecerova R., Prucek R., Soukupova J., Krystof V., et al. Antifungal activity of silver nanoparticles against Candida spp. Biomaterials 2009, 30(31):6333-6340.
8. Elechiguerra J.L., Burt J.L., Morones J.R., Camacho-Bragado A., Gao X., Lara H.H., et al. Interaction of silver nanoparticles with HIV-1. JNanobiotechnol 2005, 3:6.
9. Kalishwaralal K., BarathManiKanth S., Pandian S.R., Deepak V., Gurunathan S. Silver nanoparticles impede the biofilm formation by Pseudomonas aeruginosa and Staphylococcus epidermidis. Colloids Surf B Biointerfaces 2010, 79(2):340-344.
10. Wong K.K., Cheung S.O., Huang L., Niu J., Tao C., Ho C.M., et al. Further evidence of the anti-inflammatory effects of silver nanoparticles. ChemMedChem 2009, 4(7):1129-1135.
11. Tian J., Wong K.K., Ho C.M., Lok C.N., Yu W.Y., Che C.M., et al. Topical delivery of silver nanoparticles promotes wound healing. ChemMedChem 2007, 2(1):129-136.
12. Shrivastava S., Bera T., Singh S.K., Singh G., Ramachandrarao P., Dash D. Characterization of antiplatelet properties of silver nanoparticles. ACS Nano 2009, 3(6):1357-1364.
13. Ragaseema V.M., Unnikrishnan S., Kalliyana Krishnan V., Krishnan L.K. The antithrombotic and antimicrobial properties of PEG-protected silver nanoparticle coated surfaces. Biomaterials 2012, 33(11):3083-3092.
14. Jun B.H., Noh M.S., Kim J., Kim G., Kang H., Kim M.S., et al. Multifunctional silver-embedded magnetic nanoparticles as SERS nanoprobes and their applications. Small 2010, 6(1):119-125.
15. Mahmood M., Casciano D.A., Mocan T., Iancu C., Xu Y., Mocan L., et al. Cytotoxicity and biological effects of functional nanomaterials delivered to various cell lines. JAppl Toxicol 2010, 30(1):74-83.
16. Gurunathan S., Lee K.J., Kalishwaralal K., Sheikpranbabu S., Vaidyanathan R., Eom S.H. Antiangiogenic properties of silver nanoparticles. Biomaterials 2009, 30(31):6341-6350.
17. Nallathamby P.D., Xu X.H. Study of cytotoxic and therapeutic effects of stableand purified silver nanoparticles on tumor cells. Nanoscale 2010, 2(6):942-952.
18. Sriram M.I., Kanth S.B., Kalishwaralal K., Gurunathan S. Antitumor activity of silver nanoparticles in Dalton's lymphoma ascites tumor model. Int J Nanomedicine 2010, 5:753-762.
19. Sanpui P., Chattopadhyay A., Ghosh S.S. Induction of apoptosis in cancer cells at low silver nanoparticle concentrations using chitosan nanocarrier. ACS Appl Mater Interfaces 2011, 3(2):218-228.
20. Liu J., Zhao Y., Guo Q., Wang Z., Wang H., Yang Y., et al. TAT-modified nanosilver for combating multidrug-resistant cancer. Biomaterials 2012, 33(26):6155-6161.
21. Foldbjerg R., Olesen P., Hougaard M., Dang D.A., Hoffmann H.J., Autrup H. PVP-coated silver nanoparticles and silver ions induce reactive oxygen species, apoptosis and necrosis in THP-1 monocytes. Toxicol Lett 2009, 190(2):156-162.
22. Eom H.J., Choi J. p38 MAPK activation, DNA damage, cell cycle arrest and apoptosis as mechanisms of toxicity of silver nanoparticles in Jurkat T cells. Environ Sci Technol 2010, 44(21):8337-8342.
23. Rahban M., Divsalar A., Saboury A.A., Golestani A. Nanotoxicity and spectroscopy studies of silver nanoparticle: calf thymus DNA and K562 as targets. JPhys Chem C 2010, 114(13):5798-5803.
24. Guo D., Zhao Y., Zhang Y., Wang Q., Huang Z., Ding Q., et al. The cellular uptake and cytotoxic effect of silver nanoparticles on chronic myeloid leukemia cells. JBiomed Nanotechnol 2013, in press.
25. Thombre R., Mehta S., Mohite J., Jaisinghani P. Synthesis of silver nanoparticles and its cytotoxic effect against THP-1 cancer cell line. Int J Pharma Bio Sci 2013, 4(1):184-192.
26. AshaRani P.V., Low Kah Mun G., Hande M.P., Valiyaveettil S. Cytotoxicity andgenotoxicity of silver nanoparticles in human cells. ACS Nano 2009, 3(2):279-290.
27. Carlson C., Hussain S.M., Schrand A.M., Braydich-Stolle L.K., Hess K.L., Jones R.L., et al. Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species. JPhys Chem B 2008, 112(43):13608-13619.
28. Lim D.H., Jang J., Kim S., Kang T., Lee K., Choi I.H. The effects of sub-lethal concentrations of silver nanoparticles on inflammatory and stress genes in human macrophages using cDNA microarray analysis. Biomaterials 2012, 33(18):4690-4699.
29. Ahamed M., AlSalhi M.S., Siddiqui M.K.J. Silver nanoparticle applications and human health. Clin Chim Acta 2010, 411(23-24):1841-1848.
30. Wang Z., Liu S., Ma J., Qu G., Wang X., Yu S., et al. Silver nanoparticles induced RNA polymerase-silver binding and RNA transcription inhibition in erythroid progenitor cells. ACS Nano 2013, 7(5):4171-4186.
31. Singh R.P., Ramarao P. Cellular uptake, intracellular trafficking and cytotoxicity of silver nanoparticles. Toxicol Lett 2012, 213(2):249-259.
32. Beer C., Foldbjerg R., Hayashi Y., Sutherland D.S., Autrup H. Toxicity of silver nanoparticles - nanoparticle or silver ion?. Toxicol Lett 2012, 208(3):286-292.
33. Yang X.Y., Gondikas A.P., Marinakos S.M., Auffan M., Liu J., Hsu-Kim H., et al. Mechanism of silver nanoparticle toxicity is dependent on dissolved silver and surface coating in Caenorhabditis elegans. Environ Sci Technol 2012, 46(2):1119-1127.
34. Guo D., Zhang X., Huang Z., Zhou X., Zhu L., Zhao Y., et al. Comparison of cellular responses across multiple passage numbers in Ba/F3-BCR-ABL cells induced by silver nanoparticles. Sci China Life Sci 2012, 55(10):898-905.
35. Li L., Sun J., Li X., Zhang Y., Wang Z., Wang C., et al. Controllable synthesis of monodispersed silver nanoparticles as standards for quantitative assessment of their cytotoxicity. Biomaterials 2012, 33(6):1714-1721.
36. D'Souza A.J., Schowen R.L., Topp E.M. Polyvinylpyrrolidone-drug conjugate: synthesis and release mechanism. JControl Release 2004, 94(1):91-100.
37. Kodaira H., Tsutsumi Y., Yoshioka Y., Kamada H., Kaneda Y., Yamamoto Y., et al. The targeting of anionized polyvinylpyrrolidone to the renal system. Biomaterials 2004, 25(18):4309-4315.
38. Liu X., Xu Y., Wu Z., Chen H. Poly(N-vinylpyrrolidone)-modified surfaces for biomedical applications. Macromol Biosci 2013, 13(2):147-154.
39. Ma H., Huang S., Feng X., Zhang X., Tian F., Yong F., et al. Electrochemical synthesis and fabrication of gold nanostructures based on poly(N-vinylpyrrolidone). ChemPhysChem 2006, 7(2):333-335.
40. Wang H., Qiao X., Chen J., Wang X., Ding S. Mechanisms of PVP in the preparation of silver nanoparticles. Mater Chem Phys 2005, 94(2-3):449-453.
41. Farrag M., Thämer M., Tschurl M., Bürgi T., Heiz U. Preparation and spectroscopic properties of monolayer-protected silver nanoclusters. JPhys Chem C 2012, 116(14):8034-8043.
42. Wu J., Sun J., Xue Y. Involvement of JNK and P53 activation in G2/M cell cycle arrest and apoptosis induced by titanium dioxide nanoparticles in neuron cells. Toxicol Lett 2010, 199(3):269-276.
43. Zhao F., Zhao Y., Liu Y., Chang X., Chen C. Cellular uptake, intracellular trafficking, and cytotoxicity of nanomaterials. Small 2011, 7(10):1322-1337.
44. Chang-Liu C.M., Woloschak G.E. Effect of passage number on cellular response to DNA-damaging agents: cell survival and gene expression. Cancer Lett 1997, 113(1-2):77-86.
45. Wang K., Shindoh H., Inoue T., Horii I. Advantages of invitro cytotoxicity testing by using primary rat hepatocytes in comparison with established cell lines. JToxicol Sci 2002, 27(3):229-237.
46. Piao M.J., Kang K.A., Lee I.K., Kim H.S., Kim S., Choi J.Y., et al. Silver nanoparticles induce oxidative cell damage in human liver cells through inhibition of reduced glutathione and induction of mitochondria-involved apoptosis. Toxicol Lett 2011, 201(1):92-100.
47. Austin L.A., Kang B., Yen C.W., El-Sayed M.A. Plasmonic imaging of human oral cancer cell communities during programmed cell death by nuclear-targeting silver nanoparticles. JAm Chem Soc 2011, 133(44):17594-17597.
48. Ryter S.W., Kim H.P., Hoetzel A., Park J.W., Nakahira K., Wang X., et al. Mechanisms of cell death in oxidative stress. Antioxid Redox Signal 2007, 9(1):49-89.
49. Cooke M.S., Evans M.D., Dizdaroglu M., Lunec J. Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J 2003, 17(10):1195-1214.
50. Austin L.A., Kang B., Yen C.W., El-Sayed M.A. Nuclear targeted silver nanospheres perturb the cancer cell cycle differently than those of nanogold. Bioconjug Chem 2011, 22(11):2324-2331.
51. Ahamed M., Karns M., Goodson M., Rowe J., Hussain S.M., Schlager J.J., et al. DNA damage response to different surface chemistry of silver nanoparticles in mammalian cells. Toxicol Appl Pharmacol 2008, 233(3):404-410.
52. Park E.J., Yi J., Kim Y., Choi K., Park K. Silver nanoparticles induce cytotoxicity by a Trojan-horse type mechanism. Toxicol InVitro 2010, 24(3):872-878.
53. Pratsinis A., Hervella P., Leroux J.C., Pratsinis S.E., Sotiriou G.A. Toxicity of silver nanoparticles in macrophages. Small 2013, in press.
54. Kittler S., Greulich C., Diendorf J., Koller M., Epple M. Toxicity of silver nanoparticles increases during storage because of slow dissolution under release of silver ions. Chem Mater 2010, 22(16):4548-4554.
55. Liu J., Sonshine D.A., Shervani S., Hurt R.H. Controlled release of biologically active silver from nanosilver surfaces. ACS Nano 2010, 4(11):6903-6913.
56. Sotiriou G.A., Pratsinis S.E. Antibacterial activity of nanosilver ions and particles. Environ Sci Technol 2010, 44(14):5649-5654.
57. Navarro E., Piccapietra F., Wagner B., Marconi F., Kaegi R., Odzak N., et al. Toxicity of silver nanoparticles to Chlamydomonas reinhardtii. Environ Sci Technol 2008, 42(23):8959-8964.
58. Yu S.J., Chao J.B., Sun J., Yin Y.G., Liu J.F., Jiang G.B. Quantification of the uptake of silver nanoparticles and ions to HepG2 cells. Environ Sci Technol 2013, 47(7):3268-3274.
59. Greulich C., Diendorf J., Simon T., Eggeler G., Epple M., Koller M. Uptake and intracellular distribution of silver nanoparticles in human mesenchymal stem cells. Acta Biomater 2011, 7(1):347-354.
60. Chang Y.N., Zhang M.Y., Xia L., Zhang J., Xing G.M. The toxic effects and mechanisms of CuO and ZnO nanoparticles. Materials 2012, 5(12):2850-2871.
61. He W.W., Zhou Y.T., Wamer W.G., Boudreau M.D., Yin J.J. Mechanisms of the pH dependent generation of hydroxyl radicals and oxygen induced by Ag nanoparticles. Biomaterials 2012, 33(30):7547-7555.
62. 2. JAm Chem Soc 2003, 125(42):12803-12809.
63. Liu J., Hurt R.H. Ion release kinetics and particle persistence in aqueous nano-silver colloids. Environ Sci Technol 2010, 44(6):2169-2175.